Fusion Pharmaceuticals Inc. - Special Call Transcript
Good morning, and welcome to the Fusion Pharmaceuticals announces collaboration with AstraZeneca conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Amanda Cray, Senior Director of Investor Relations and Corporate Communications. Please go ahead.
Thank you, Alyssa, and thank you all for joining today's call. This morning, we issued a press release regarding a strategic collaboration with AstraZeneca to discover, develop and commercialize next-generation radiopharmaceuticals and combination therapies. The press release is available on our website at fusionpharma.com.
Joining us on the call today are Chief Executive Officer, John Valliant; Chief Financial Officer, John Crowley; Chief Scientific Officer, Eric Burak; Chief Medical Officer, Jim O'Leary; and Senior Vice President of Business Development, Marc Schwabish. After our prepared remarks, we'll open the call for questions.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |